ognizant Communication Corporation

EDITORIAL ADVISORY BOARD

American Continent: Alan C. Sartorelli, Co-Editor-in-Chief, and Edward Chu, Co-Editor-in-Chief
K. W. Bair, EntreMed, Inc., Rockville, MD, USA
J. R. Bertino, Cancer Institute of New Jersey, USA
R. A. Bradshaw, University of California, Irvine, USA
Y.-C. Cheng, Yale University School of Medicine, USA
R. L. Erikson, Harvard University, USA
W. N. Hait, Cancer Institute of New Jersey, USA
S. M. Hecht, University of Virginia, USA
L. H. Hurley, Arizona Cancer Center, Tucson, USA
P. A. Jones, University of Southern California, USA
J. S. Lazo, University of Pittsburgh School of Medicine, USA
G. Litwack, Jefferson Cancer Institute, Philadelphia, PA, USA
J. W. Lown, University of Alberta, Canada
L. A. Loeb, University of Washington, USA
S. Pestka, UMDNJ-Robert Wood Johnson Medical School, USA
G. R. Pettit, Cancer Research Institute, Arizona, USA
Y. G. Pommier, National Cancer Institute, Bethesda, MD, USA
G. Powis, Arizona Cancer Center, USA
M. Reiss, Cancer Institute of New Jersey, USA
J. Siegfried, University of Pittsburgh School of Medicine, USA
E. J. Stanbridge, University of California, Irvine, USA
C. Stein, Albert Einstein College of Medicine, USA

European Continent: Romano Danesi, Co-Editor-in-Chief
C. Bailly, Institute de Recherchés sur le Cancer de Lille, France
M. Beato, Philipps-Universität, Germany
A. H. Calvert, University of Newcastle upon Tyne, United Kingdom
M. D'Incalci, Institute di Ricerche Farmacologiche, Italy
W. Fiers, University of Ghent, Belgium
L. Frati, University of Rome, Italy
D. Givol, The Weizmann Institute of Science, Israel
A. L. Harris, Churchill Hospital, United Kingdom
I. Hickson, Cancer Research UK, Oxford, United Kingdom
A. Levitzki, Hebrew University of Jerusalem, Israel
M. F. Rajewsky, Universität Essen, Germany
D. Shugar, Academy of Sciences, Poland
M. F. G. Stevens, University of Nottingham, United Kingdom
D. Thurston, University of London, United Kingdom
A. S. Tsiftsoglou, Aristotle University of Thessaloniki, Greece
G. Vecchio, Università Degli Studi di Napoli Federico II, Italy
M. J. Waring, University of Cambridge, United Kingdom
P. Workman, CRC Center for Cancer Therapeutics, United Kingdom

Asia and Pacific Rim: Kazuo Umezawa, Co-Editor-in-Chief
Y.-J. Bang, SNU Cancer Research Institute, Korea
B. C. Baguley, Auckland Cancer Society Research Center, New Zealand
A.-Y. Chang, National University Hospital, Singapore
W. A. Denny, University of Auckland, New Zealand
T. Irimura, University of Tokyo, Japan
C.-M. Kim, National Cancer Center, Korea
K. Kohno, University of Occupational & Environmental Health, Kitakyushu, Japan
J.-K. Lin, National Taiwan University, Republic of China
Y. Maehara, Kyushu University, Japan
A. Matsuda, Hokkaido University, Japan
K. Miyazaki, Yokohama University, Japan
I. Saiki, Toyama Medical and Pharmaceutical University, Japan
T. Sakai, Kyoto Prefectural University of Medicine, Japan
Y. Satoh, Tohoku University, Japan
C. Shou, Beijing Institute for Cancer Research, China
K. Umezawa, Keio University, Japan